PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: October 2010
WHO Brings Big Pharma Together to Fight Debilitating Diseases
A new report from WHO on overcoming the impact of neglected tropical diseases has spawned a $150 million funding and donation initiative from Big Pharma.
Last week, the World Health Organization (WHO) announced an initiative involving six Pharmaceutical companies—Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Bayer, and Eisai of Japan—that will bring much-needed funding and research to [...]
Pfizer to Acquire King Pharmaceuticals
The merger, announced on Tuesday, will cost Pfizer $3.6 billion.
Pfizer and King Pharmaceuticals announced on Tuesday they have entered into a definitive friendly merger agreement. Under the terms, Pfizer will acquire King, a diversified specialty pharmaceutical company based in Tennessee, for $3.6 billion in cash, or $14.25 per share. The company emphasized the deal is not [...]
Financial Woes Affect Cancer Patients’ Treatment Decisions
A recent survey conducted by MDLinx reveals that 95 percent of the nation’s oncologists report a rise in their patients’ concerns over treatment costs in the past six months.
Of the 106 US oncologists surveyed in a MDLinx survey last month, 84 percent said they had invested more time and effort into the financial planning of [...]
Global Market for Medicines: Regional Balance in Growth Continues to Shift, While Pipelines Begin to Show Some Promise
The predicted five percent to seven percent growth of the global pharma industry surpasses the four to five percent pace of increase from 2010.
According to a forecast released last week by IMS Health, the value of the global pharmaceutical market is expected to grow five percent to seven percent next year, reaching $880 billion.
The IMS [...]
2010: A Year of Big Layoffs for Big Pharma